Background: Patients with atrial fibrillation (AF) have a higher risk of fatal complications (eg,
stroke). This investigation was performed as an observational retrospective cohort study …

Background—The objective of this study was to evaluate the added predictive ability of the
CHA2DS2VASc prediction rule for stroke and death in a nonanticoagulated population of …

INTRODUCTION AND OBJECTIVES: The risk of stroke in atrial fibrillation is heterogeneous
and depends upon underlying clinical conditions included in current risk stratification …

North American and European guidelines on atrial fibrillation (AF) are conflicting regarding
the classification of patients at low/intermediate risk of stroke. We aimed to investigate if the …

Background and Objectives: Atrial fibrillation (AF) is associated with increased mortality,
predictors of which are poorly characterized. We investigated the predictive power of the …

Objectives The CHA2DS2-VASc score is the preferred risk model for anticoagulation
decision-making in atrial fibrillation (AF) patients. Recent studies have found this score to …

Objective To perform a systematic review and meta-analysis of the predictive abilities of
CHADS 2 and CHA 2 DS 2-VASc in stroke and thromboembolism risk stratification of atrial …

BACKGROUND AND METHODS: The CHA2DS2-VASc score has been newly proposed for
stratifying patients with nonvalvular atrial fibrillation (AF) according to the risk of ischemic …

Two validated scoring systems for predicting embolic risk, CHADS2 and CHA2DS2-VASc,
contribute to optimizing antithrombotic prescription practices in patients who have atrial …

Stroke and CHA2DS2‐VASc Score= 0. Objectives: Patients with atrial fibrillation (AF) and a
CHA2DS2‐VASc score= 0 have a very low risk of stroke and current guidelines even …